| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
CAMBRIDGE, Mass.—Multidrug treatments are becoming increasingly prevalent but little effort has gone into determining whether the drugs will interact with each other in unexpected ways. Researchers at Harvard University therefore examined a series of antibiotics for their impact pair-wise on bacteria and classified the drugs into distinct families. They presented their work in Nature Genetics (2006, 38, 489-494).
 
The scientists used a bioluminescence assay of E. coli growth rates to measure the impact of pairs of antibiotics at sublethal doses. They categorized the pairings as additive, synergistic, antagonistic buffering or antagonistic suppression, and then used the Prism algorithm to classify the drugs into subgroups. They found that most drugs classified easily into interaction groups. Interestingly, compound similarities within each subgroup were based on cellular function rather than chemical structure.
 
They also found that drugs they could not subgroup often impacted more than one biological pathway, while drugs that classified into their own group often exhibited novel mechanisms-of-action. These last two points offer possible insights into the battle to combat drug resistance in microbes or cancer cells.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
A 3D-rendered illustration of a eukaryotic cell highlighting organelles such as the nucleus, endoplasmic reticulum, mitochondria, and cytoskeletal structures in pink and purple tones.

Shining light on the subcellular proteome

Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue